Biomira, Inc.
17Patents
0Active
17Granted
32Portfolio score
Filing activity: Feb 1, 1988 → Nov 7, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5110911A | Human tumor-associated Thomsen-Friedenreich antigen | Emerging Cross-Sectional Technologies | 52 | Expired |
| US6600012B1 | Lipid-modified muc-1 derivatives | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6013779A | Process for preparation of glycosides of tumor-associated carbohydrate antigens | Chemistry; Metallurgy | 19 | Expired |
| US5075218A | Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5055562A | Fluorocarbon chain-containing antigenic conjugates | Human Necessities | 14 | Expired |
| US5242799A | Lectin-antibody immunoassays for TF epitope-bearing antigens | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5798090A | Enhancement of the cellular immune response | Human Necessities | 8 | Expired |
| USRE38046E1 | Enhancement of the cellular immune response | General | 7 | Expired |
| US4935503A | Azidochlorination and diazidization of glycals | Chemistry; Metallurgy | 6 | Expired |
| US7491707B1 | Synthetic lipid-a-analogs and uses thereof | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4971795A | Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype | Human Necessities | 5 | Expired |
| US6114129A | Methods of detecting T-cell activation and treating disorders associated with T-cell dysfunction | Physics | 3 | Expired |
| US5527891A | Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5837830A | Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5455332A | Carcinoma-marking monoclonal antibodies elicited with synthetic Asialo-GM1 antigen | Chemistry; Metallurgy | 1 | Expired |
| US6582697B2 | Enhancement of the cellular immune response | Human Necessities | 0 | Expired |
| US6326009A | Enhancement of the cellular immune response | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.